<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> is an inherited <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes </plain></SENT>
<SENT sid="1" pm="."><plain>Mutation carriers have a high risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but do not present with <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e>, a typical feature of other <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> syndromes such as <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e>, in which <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> reflects the high frequency of biallelic APC gene inactivation </plain></SENT>
<SENT sid="2" pm="."><plain>We asked whether in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> biallelic inactivation of MMR genes occurred at a similar frequency to that of APC gene, and whether MMR inactivation resulted in detectable lesions within the intestinal mucosa </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Resections done for small and <z:e sem="disease" ids="C0009402" disease_type="Neoplastic Process" abbrv="CRC">large bowel cancer</z:e> between January, 2002, and January, 2011, were retrieved </plain></SENT>
<SENT sid="4" pm="."><plain>We systematically analysed non-tumorous mucosa from carriers of a <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> mutation (set 1: ten patients) and control patients without <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (set 1: nine patients) for MMR protein expression (MLH1, MSH2, and EPCAM) with immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>We validated the findings in an independent sample set (set 2: 30 Lynch syndrome patients, 79 controls) </plain></SENT>
<SENT sid="6" pm="."><plain>We did an analysis of microsatellite instability by PCR analysis to test lesions for mismatch repair deficiency </plain></SENT>
<SENT sid="7" pm="."><plain>We applied a Poisson regression model to analyse the distribution of MMR-deficient crypt foci counts and a Fisher's exact test to compare the prevalence of these foci between mutation carriers and control patients </plain></SENT>
<SENT sid="8" pm="."><plain>FINDINGS: 20 crypt foci with no MMR protein expression were detected in 20路1 cm(2) of non-tumorous mucosa from <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> patients (set 1), an additional five were detected upon resectioning of two samples </plain></SENT>
<SENT sid="9" pm="."><plain>In an independent validation set (set 2), two MMR-deficient crypt foci were noted in 2路2 cm(2) of mucosa </plain></SENT>
<SENT sid="10" pm="."><plain>No MMR-deficient crypt foci were noted in non-tumorous mucosa from control patients without evidence for <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (set 1: 3路7 cm(2), set 2: 4路8 cm(2)) </plain></SENT>
<SENT sid="11" pm="."><plain>Microsatellite instability was detected in <z:hpo ids='HP_0000001'>all</z:hpo> seven MMR-deficient crypt foci analysed </plain></SENT>
<SENT sid="12" pm="."><plain>A subset of these foci displayed unusual architectural and cytological abnormalities, although they had no polypous or adenomatous appearance </plain></SENT>
<SENT sid="13" pm="."><plain>INTERPRETATION: We identified a novel type of lesion, the MMR-deficient crypt focus, as the manifestation of biallelic MMR gene inactivation in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The abundance of MMR-deficient crypt foci indicates a high frequency of biallelic MMR gene inactivation, which is in sharp contrast with the low number of clinically manifest <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>This discrepancy suggests that most MMR-deficient crypt foci do not progress to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>We propose <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> as a unique model syndrome for studying initial steps of MMR deficiency, <z:e sem="disease" ids="C0598935" disease_type="Neoplastic Process" abbrv="">tumour initiation</z:e> and, possibly, elimination </plain></SENT>
<SENT sid="17" pm="."><plain>FUNDING: German <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Aid and German Research Foundation </plain></SENT>
</text></document>